Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Continuous glucose monitoring in youth with cystic fibrosis treated with lumacaftor-ivacaftor

Continuous glucose monitoring in youth with cystic fibrosis treated with lumacaftor-ivacaftor

Resource Type

CF Research News

Authors

Angel Li, TimVigers, Laura Pyle, Edith Zemanick, Kristen Nadeau, Scott D. Sagel, Christine L. Chan

References

J Cyst Fibros. 2018 Aug 10. pii: S1569-1993(18)30718-5. doi: 10.1016/j.jcf.2018.07.010

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

continuous glucose monitoring [3]
Cystic fibrosis related diabetes [4]
Cystic fibrosis transmembrane conductance regulator protein modulator [5]

Date

Friday, August 10, 2018

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [6]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/continuous-glucose-monitoring-youth-cystic-fibrosis-treated

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-18-00152R1_Chan_FINAL_270818.pdf [2] https://www.ncbi.nlm.nih.gov/pubmed?term=continuous%20glucose%20monitoring%20in%20youth%20with%20cystic%20fibrosis%20related%20with%20lumacaftor-ivacaftor&cmd=correctspelling [3] https://www.ecfs.eu/research-article-keywords/continuous-glucose-monitoring [4] https://www.ecfs.eu/research-article-keywords/cystic-fibrosis-related-diabetes [5] https://www.ecfs.eu/research-article-keywords/cystic-fibrosis-transmembrane-conductance-regulator-protein-modulator [6] https://www.ecfs.eu/resource-guideline-type/other-guidelines